Biotech Acquisition

NASDAQ: BIOTU · Real-Time Price · USD
10.14
-0.05 (-0.49%)
At close: Feb 02, 2023, 8:53 PM

Biotech Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
n/a
Cost of Revenue
1.57M
Gross Profit
-1.57M
Operating Income
-1.57M
Interest Income
n/a
Pretax Income
-6.87M
Net Income
-12.16M
Selling & General & Admin
n/a
Research & Development
n/a
Other Expenses
1.57M
Operating Expenses
n/a
Interest Expense
5.29M
Selling & Marketing Expenses
n/a
Cost & Expenses
1.57M
Income Tax Expense
5.29M
Shares Outstanding (Basic)
28.75M
Shares Outstanding (Diluted)
28.75M
EPS (Basic)
-0.42
EPS (Diluted)
-0.42
EBITDA
-6.87M
EBIT
-1.57M
Depreciation & Amortization
-5.29M